荣泰健康
(603579)
| 流通市值：48.36亿 | | | 总市值：48.36亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 394,971,319.77 | 1,596,868,348.54 | 1,164,316,596.07 | 824,918,018.49 |
| 营业收入 | 394,971,319.77 | 1,596,868,348.54 | 1,164,316,596.07 | 824,918,018.49 |
| 二、营业总成本 | 359,966,503.86 | 1,435,026,128.54 | 1,027,733,709.64 | 716,349,779.94 |
| 营业成本 | 266,434,319.74 | 1,090,976,703.61 | 786,711,497.71 | 551,293,930.67 |
| 税金及附加 | 4,904,582.46 | 13,548,506.3 | 9,870,840.75 | 5,572,085.08 |
| 销售费用 | 42,292,214.01 | 179,603,370.11 | 125,232,032.89 | 90,107,784.79 |
| 管理费用 | 19,462,326.83 | 86,713,089.22 | 57,521,268.96 | 41,738,443.48 |
| 研发费用 | 21,310,597.42 | 80,104,026.4 | 57,007,658.8 | 38,122,653.47 |
| 财务费用 | 5,562,463.4 | -15,919,567.1 | -8,609,589.47 | -10,485,117.55 |
| 其中:利息费用 | 7,360,620.7 | 5,901,938.34 | 3,591,417.78 | 2,132,660.95 |
| 其中:利息收入 | 1,955,899.34 | 15,044,827.35 | 12,631,875.27 | 10,030,607.88 |
| 加:公允价值变动收益 | 2,556,694.34 | -6,141,569.1 | -920,780.53 | 2,588,809.68 |
| 加:投资收益 | 12,665,617.75 | 38,839,839.16 | 18,344,311.54 | 8,605,112.96 |
| 资产处置收益 | 226,210.51 | 703,339.52 | -109,812.47 | -109,812.47 |
| 资产减值损失(新) | - | -5,046,504.18 | -1,910,238.52 | -434,965.22 |
| 信用减值损失(新) | -692,957.59 | 914,913.83 | -1,436,988.53 | -2,018,344.73 |
| 其他收益 | 3,488,669.46 | 19,288,241.83 | 7,290,170.52 | 4,808,404.89 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 53,249,050.38 | 210,400,481.06 | 157,839,548.44 | 122,007,443.66 |
| 加:营业外收入 | 13,573.71 | 233,169.93 | 124,278.85 | 122,088.05 |
| 减:营业外支出 | 281,964.68 | 639,531.66 | 380,085.09 | 376,832.3 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 52,980,659.41 | 209,994,119.33 | 157,583,742.2 | 121,752,699.41 |
| 减:所得税费用 | 8,982,423.3 | 18,186,266.5 | 14,791,959.18 | 10,378,826.83 |
| 六、净利润 | 43,998,236.11 | 191,807,852.83 | 142,791,783.02 | 111,373,872.58 |
| 持续经营净利润 | 43,998,236.11 | 191,807,852.83 | 142,791,783.02 | 111,373,872.58 |
| 归属于母公司股东的净利润 | 43,938,868.26 | 191,945,865.16 | 142,512,054.98 | 111,336,627.48 |
| 少数股东损益 | 59,367.85 | -138,012.33 | 279,728.04 | 37,245.1 |
| (一)基本每股收益 | 0.25 | 1.11 | 0.82 | 0.64 |
| (二)稀释每股收益 | 0.24 | 0.97 | 0.72 | 0.58 |
| 八、其他综合收益 | 24,113,355.17 | 17,456,935.93 | -7,756,276.24 | -18,903,963.89 |
| 归属于母公司股东的其他综合收益 | 24,131,118.94 | 17,493,057.54 | -7,715,397.18 | -18,872,732.92 |
| 九、综合收益总额 | 68,111,591.28 | 209,264,788.76 | 135,035,506.78 | 92,469,908.69 |
| 归属于母公司股东的综合收益总额 | 68,069,987.2 | 209,438,922.7 | 134,796,657.8 | 92,463,894.56 |
| 归属于少数股东的综合收益总额 | 41,604.08 | -174,133.94 | 238,848.98 | 6,014.13 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |